Study links mutations in RAD51C gene to breast and ovarian cancer

[News]

The discovery 15 years ago that the genes BRCA1 and BRCA2 confer high risks for breast and ovarian cancer was a breakthrough for cancer prediction and therapy, especially for familial cases. Now the research group of Prof. Alfons Meindl (Klinikum rechts der Isar of the Technische Universitaet Muenchen), in collaboration with other groups from Germany, the U.K., and the U.S., can identify another gene that increases susceptibility to breast and ovarian cancer.

More... (http://www.news-medical.net/news/20100422/Study-links-mutations-in-RAD51C-gene-to-breast-and-ovarian-cancer.aspx)